Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA). Clinical rheumatology. 2017;36(4):773-9.

28/02/2022

Iannone F, Courvoisier DS, Gottenberg JE, Hernandez MV, Lie E, Canhão H, et al.

Epub 2016/12/15. doi: 10.1007/s10067-016-3505-5. PubMed PMID: 27966068.